## VTR: Ventas, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -1.0% below STRENGTH zone (4.0-10.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($74.89)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. VIRGINIA RETIREMENT SYSTEMS ET Al Sells 52,000 Shares of Ventas, Inc. $VTR**
- Source: MarketBeat | 20260101T113708 | Neutral | Relevance: 100%
- VIRGINIA RETIREMENT SYSTEMS ET Al reduced its stake in Ventas, Inc. by 23.6%, selling 52,000 shares and retaining 167,970 shares valued at $11.76 million. Institutional investors now hold approximately 94.18% of the company, while insiders sold a combined 673,268 shares worth about $49.68 million in the past three months. Analysts maintain a "Moderate Buy" rating for Ventas with a target price of $79.31, following strong Q3 results and a set FY2025 EPS guidance.

**2. Tangible book value per share of Ventas, Inc. – GETTEX:VEN**
- Source: TradingView — Track All Markets | 20260103T000853 | Neutral | Relevance: 100%
- This article provides information on the tangible book value per share of Ventas, Inc. (GETTEX:VEN). It presents a specific financial metric for the company, accessible through a market data platform. The content focuses solely on this financial data point for Ventas.

**3. Vanderbilt University Sells 15,485 Shares of Ventas, Inc. $VTR**
- Source: MarketBeat | 20260101T123254 | Neutral | Relevance: 100%
- Vanderbilt University reduced its stake in Ventas, Inc. (NYSE:VTR) by 38.2% in Q3, selling 15,485 shares and retaining 25,026 shares valued at $1.75 million. High insider selling activity was noted, with the CEO and CFO offloading significant shares, while other institutional investors like Merit Financial Group and Diversified Trust Co. increased their positions. Ventas declared a quarterly dividend of $0.48, and analysts have a "Moderate Buy" rating with a consensus price target of $79.31.

**4. Ventas Stock: Quiet Year-End Rally Puts This Healthcare REIT Back On Income Investors’ Radar**
- Source: AD HOC NEWS | 20260101T024642 | Bullish | Relevance: 100%
- Ventas, a healthcare REIT focused on senior housing, has experienced a quiet but persistent year-end rally, recovering from its 52-week lows. This uptrend, backed by improving senior housing fundamentals and stabilizing interest rates, suggests a shift in market sentiment towards healthcare REITs. The stock's one-year performance has been rewarding for investors, with ongoing portfolio optimization and a constructive Wall Street verdict pointing to continued upward potential.

**5. Ventas Inc. stock outperforms competitors despite losses on the day**
- Source: MarketWatch | 20251231T165400 | Somewhat-Bearish | Relevance: 100%
- Ventas Inc. (VTR) shares fell 1.26% to $77.38 on Wednesday, despite outperforming the S&P 500 Index and Dow Jones Industrial Average, which also saw losses. This marks the second consecutive day of declines for Ventas Inc. stock.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Keybanc | $85 | $70 | +21% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($3.41M) |
| Sells | 11 ($22.87M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 62.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 15.7% (+2.5%)
- JPMORGAN CHASE & CO: 12.7% (+102.6%)
- Blackrock Inc.: 11.1% (+2.6%)
- State Street Corpora: 6.2% (+3.3%)
- FMR, LLC: 5.7% (+12.1%)

### Key Risks

1. Heavy insider selling: $23M sold (11 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Analyst sentiment positive (1 raises, avg +21%). Insider selling cluster ($22.9M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $36.3B |
| Beta | 0.79 |
| 52W Range | $56.68 - $81.89 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 136.9 |
| Current P/E | 286.4 |
| YoY Growth | 109.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 stable at -1.0% (minimal 5-day change). Below STRENGTH zone by 5.0pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.11x) but short-term weakness (below SMA20). RSI neutral at 42. OFD pattern: -DBN (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.04% (CS: 27) | Neutral |
| RSI_14 | 42.1 | Neutral |
| MACD Histogram | -0.36 | Bearish |
| vs SMA20 | 0.979x | Below |
| vs SMA50 | 1.000x | Below |
| vs SMA200 | 1.115x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $77.33
- **Stop Loss:** $74.89 (3.2% risk)
- **Target:** $79.77 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 590
- **Position Value:** $45,624.70
- **Portfolio %:** 45.62%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-11 (Est: $0.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.12 | +141.9% |
| 2025Q2 | $0.14 | $0.15 | +10.4% |
| 2025Q1 | $0.07 | $0.10 | +35.8% |
| 2024Q4 | $0.05 | $0.13 | +156.6% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*